TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: proportion of patients with hemodynamic support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Working memory accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time during working memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting state functional connectivity between the left inferior parietal lobule and the regions of the frontoparietal control network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resting state functional connectivity within the default mode network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total Severity of External Lymphedema and Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root Mean Square (RMS) swaying of COG in X,Y,Z
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of swaying in X,Y,Z
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Time to Real-World Progression-Free Survival (rwPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Average Nighttime Heart Rate Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Repeated Chair Stand Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality at 28 days after randomization
Endpoint domain: Mortality/survival
Primary endpoint: Interoception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cue-Reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhanced recovery score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to composite of poor outcomes
Endpoint domain: Mortality/survival
Primary endpoint: Wound Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial Colony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cytokine and Growth Factor Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: blood monocytes trained immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of men who have self-tested for HIV
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of men with confirmed HIV-positive results who have been linked to HIV care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of linked HIV-positive men who have been retained in HIV care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early mobilization
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Surgery-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in Quality of Life scoring (FI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse event reporting (Safety)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Categorized Based on Treatment by Narcolepsy Type Since Diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants Categorized Based on Non-Pharmacological Treatments Patterns by Treatment Status
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Treated or Naïve (Untreated) Participants for the Type of Pharmacological Treatment Status Since Diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants With the Use of Each Type of Treatment Stratified by Type of Hospital
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participation rate of eligible smokers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Functional results using the Oxford score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Attitude toward mode of delivery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference of delivery mode
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Disc T2 relaxation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Hairs Shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PA levels (time spent in moderate to vigorous physical activity)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Relief of TMD Signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased range of painless jaw movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reach of the intervention (VISACT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cefazolin plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUClast of IVL3003
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of IVL3003
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast of Aricept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of Aricept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of breast mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accrual rate of 1 or more per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion rate of 70% or more
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HAE Attack Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Time Interval Between HAE Attacks in Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to administration of initial dose of amiodarone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of HBsAg decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck pain and disability scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Copenhagen neck functional disability scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: KOOS - Pain subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in hand lentigines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: New-onset of gastroesophageal reflux disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Knowledge Level on Pregnancy Diabetes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total Antioxidant Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sperm DNA Fragmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: % of histone-rich spermatozoa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: poor quality sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Geriatric Depression Scale (GDS-15)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfaction with Life (SWL) scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Whole blood counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cytokine production upon monocyte stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reactive oxygen species (ROS) production by monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of early detection of cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Duration of crying
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in activation in global CD8 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Headache Impact Test-6
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Distance between the rectus abdominus muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Number of Binge Eating Days per Week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical Changes in Blood Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall physical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2 max.
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of ceased or dose lowered drugs per patient
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Salivary Amylase Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Salivary Cortisol Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean/Median proportion of folic acid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean/Median proportion of vitamin B12 intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Concentration Time Curve (AUC) of Brensocatib in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC∞ Plasma Brensocatib/Plasma Total Radioactivity Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount Excreted in Urine (Aeu) of Brensocatib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of viral and bacterial pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement on Montreal Cognitive Assessment test of 5 points or more than baseline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: AUC0-t for single-dose NX-5948 tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf for single-dose NX-5948 tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for single-dose NX-5948 tablet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical Jump Variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Umbilical blood Base Excess (BE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of patient-oriented composite endpoints (POCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interstitial Lung Disease quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acceptability of Health Workers Training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of Health Workers Training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Health Workers Training
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants with HBV DNA lower than threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: duration of surgical procedure in minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: maxillomandibular fixation stability in nominal scale (stable-unstable)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral hygiene measuring with Oral Hygiene Index-Simplified (OHI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic work of breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk of SGLT2 inhibitor-associated DKA
Endpoint domain: Adverse events/effects
Primary endpoint: POTS questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sleep diary indicators
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Readiness for Hospital Discharge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in average percent Off time during waking hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Variceal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in PROMIS-29 v2.0 Profile
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Fibromyalgia impact questionnaire (FIQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Serum concentration of copeptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived barriers to exercise
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: PreP uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PreP adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PreP persistence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICU-acquired anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain measurement using VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain measurement using mechanical algometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Evoked Compound Action Potentials (ECAPs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of Cardiovascular Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of cardiovascular Risk Factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative change from baseline to 4 weeks in systemic Interleukin-6 (IL-6) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Patients With AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence Rate of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Vibration Perception Threshold (VPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of a severe form of IgA nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Modified bass test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Light Touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Two-Point Discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vibration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Position Sense Reproduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gait Analysis- Step Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Analysis- Walking Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of precancerous lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of anal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: RRT dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Ankle and Foot Outcome Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Function Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of the length and width of the foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post infusion recovery of Test platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Post infusion survival of Test platelets
Endpoint domain: Mortality/survival
Primary endpoint: Overall Clinical Response (OCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with at Least One Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Who Discontinued Medication Due to an AE
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Placement accuracy Box
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent accuracy Serial Seven Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: VAS-score for mental fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Successful randomization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Delivery of Magnesium (Mg) or saline bolus within 2 hours after ROSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful serum draw and analysis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of Cerebral Performance Category Score (CPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brown fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise-induced muscle damage measured through the countermovement jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Exercise-induced muscle recovery through the DOMS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in sensitivity for PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sensitivity for MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the standardized uptake value (SUV) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Workers With Opioid Misuse
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Workers With Opioid Use Disorder
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Workers With Opioid Overdose
Endpoint domain: Adverse events/effects
Primary endpoint: amount of postoperative morphine consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First postoperative analgesics request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: crown retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival at longest follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Phase II recommended dose (RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of VOEs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool acetate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in number of target laboratory tests ordered per patient-day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child eating behaviours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Perceived health risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with non-fatal myocardial infarction or all-cause stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with major amputation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ex vivo spontaneous lymphoproliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: The rate of cardiovascular and/or cardiometabolic diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: withdrawal time compliance rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AI-Flex ECG Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AI-Flex Temperature Measurement Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AI-Flex PPG Measurement Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alveolar ventilation per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes